| Ticker |
MTRY
|
| CIK | 0001860663 |
| SIC | 6770 |
| Sector | Finance, Insurance, And Real Estate |
| Industry Category | Trading |
| Industry Group | Investment Offices |
| Address | 17 STATE STREET, 21ST FLOOR, NEW YORK, NY, 10004 |
| Website | montereybio.com |
| Phone | 917-267-0216 |
| CEO | Sanjeev S. PhD |
| Employees | N/A |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Monterey Bio Acquisition Corp. Announces Rebrand and Management ChangesMonterey Bio Acquisition Corporation (Nasdaq: MTRYU) today announced a rebrand to Monterey Innovation Acquisition Corp. ("Monterey Innovation" or "the Company"), expanding its acquisition strategy to include a broader universe of disruptive technology targets, which is further enabled by key additions to the board of directors and changes to the Company's management team. Monterey Bio Acquisition Corporation (NASDAQ:MTRY) has caught the attention of institutional investors who hold a sizeable 41% stakeTo get a sense of who is truly in control of Monterey Bio Acquisition Corporation ( NASDAQ:MTRY ), it is important to... Do Institutions Own Monterey Bio Acquisition Corporation (NASDAQ:MTRY) Shares?A look at the shareholders of Monterey Bio Acquisition Corporation ( NASDAQ:MTRY ) can tell us which group is most... Monterey Bio Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing November 22, 2021Monterey Bio Acquisition Corporation (the "Company") announced today that, commencing November 22, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade shares of the Company's common stock and warrants included in the units. Monterey Bio Acquisition Corporation Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Option to Purchase Additional UnitsMonterey Bio Acquisition Corporation ("Monterey Bio" or the "Company") (Nasdaq: MTRYU) today announced the closing of its previously announced initial public offering of 10,000,000 units, at a price to the public of $10.00 per unit. The Company also announced that the underwriter had exercised in full its option to purchase 1,500,000 additional units, with the option expected to close on October 6, 2021, subject to customary closing conditions. Each unit consists of one share of common stock and |
